#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thermal burn Uveal melanoma Peritoneal mesothelioma malignant Peritoneal neoplasm Proteus syndrome Glioblastoma Cortical dysplasia Stiff person syndrome Tourette's disorder Anal fistula Leukoencephalopathy Plasma cell myeloma Squamous cell carcinoma of the hypopharynx Fatty acid oxidation disorder Oesophageal carcinoma More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa – Diagnostics Shprintzen-Goldberg syndrome – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Langerhans’ cell histiocytosis – Basic Information Optic glioma – Basic Information Familial haemophagocytic lymphohistiocytosis – Treatment Rett syndrome – Trials in Disease Netherton’s syndrome – Basic Information Hyperoxaluria – Treatment Gaucher’s disease type III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pristinamycin Vinflunine Tiotropium Imatinib Nemolizumab Levamisole Hydrochloride Specific Nucleic Acid Sna-Xfsa Meropenem Grwd5769 Cenegermin Cefiderocol Glucose Monohydrate Ceftazidime Trazodone Citalopram Anhydrous Caffeine Metoclopramide Hydrochloride Dorzolamide Quc398 Nirmatrelvir More therapies…

    Learn about Your Condition

    Developmental hip dysplasia Acute respiratory failure Hypertrophic cardiomyopathy Primary hypercholesterolaemia Nasal sinus cancer Primary adrenal insufficiency Glomerulonephritis membranous Procedural haemorrhage Rhabdomyosarcoma Genital infection female Tubulointerstitial nephritis Paresis Sexual dysfunction Periodontitis Metastatic glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Mitapivat on Brain Blood Flow and Oxygen Use in Patients with Sickle Cell Anemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Mitapivat
    The Netherlands

  • Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    The Netherlands

  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    • Thymic carcinoma
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Fluorouracil
    France

  • Study on Nicotinamide for Patients with Acute Kidney Injury

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • Nicotinamide
    France

  • Study on the Use of PRGF Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Italy Poland Spain
Previous Page
1 … 793 794 795 796 797 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!